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he role of CTLA-4 in immune regulation
The role of cytotoxic T-lymphocyte-associated antigen-4
CTLA-4; CD152) in the regulation of T cell activation remains
much debated topic. A type I transmembrane protein of
he immunoglobulin superfamily and homologue of the co-
timulatory molecule CD28, CTLA-4 serves a crucial role
n negative regulation of the T cell immune response. Mice
eficient in CTLA-4 develop spontaneous lymphoprolifera-
ive disease with multiorgan infiltration within 3–4 weeks of
irth, suggesting aberrant regulation of T cell activation or
roliferation. Several theories have been postulated to explain
he observed manifestation of spontaneous disease. First, the
bserved dysregulation could result from an impaired function
f T regulatory (Treg) cells, since CTLA-4 has been shown
o be constitutively expressed on the surface and in the cyto-
lasm of peripheral CD4+CD25+ Treg cells [1]. Several studies
sing neutralizing monoclonal antibody to block CTLA-4 on
reg cells in vivo have reported an exacerbation of autoimmune
isease [1,2]. In contrast to these findings, B7-1/B7-2/CTLA-4-
eficient mice showed FoxP3 expression on 2.5–3% of CD4+
ells, representing Treg cells that are functional in vitro [3]. The
mportance of CTLA-4 for Treg cell function therefore remains
o be elucidated.
A second explanation for the augmented lymphoprolifera-
ion observed in CTLA-4−/− mice could be a lower activation
hreshold in CTLA-4 deficient effector T cells. CTLA-4 has been
uggested to regulate the threshold for activation in response to
ndogenous rather than exogenous antigens [4,5]. CTLA-4 has
urther been suggested to play a role in the negative selection of
cells in the thymus [6,7]. A deficiency in CTLA-4 might there-
ore give rise to a hyperresponsive T cell population, leading to
isproportionate T cell proliferation and organ infiltration.
The current study elaborates on an altogether new explana-
ion for the observed lymphoproliferation. In recent studies, the
udd group have made several interesting observations regard-
ng the effect of CTLA-4 on T cell motility. First, CTLA-4
igation was shown to upregulate the expression of lymphocyte
unction-associated antigen-1 (LFA-1) [8]. LFA-1 plays a crucial
ole in promoting clustering of T cells with antigen present-
ng cells (APCs), therefore facilitating antigen presentation and
ctivation. Interestingly, anti-CD3/CTLA-4 co-ligation simul-
aneously led to the inhibition of IL-2 production. Moreover,
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Open access under CC BY license.yperactivation of adhesion is often accompanied by increased
otility and migration of T cells, which could limit the num-
er of engaged TCRs and therefore limit the antigen-specific
esponse. The same stimulation could therefore lead to either
positive or negative response, depending on factors such as
uration and combined strength of signalling.
The importance of signal duration in addition to quality and
uantity was further supported by findings on the effect of
TLA-4 on the TCR stop signal [9]. Comparison of the mobility
f CTLA-4+/+ and CTLA-4−/− CD4+ cells on plates coated with
he LFA-1 ligand, intercellular adhesion molecule-1 (ICAM-1),
howed that whereas pre-activated T cells from either group
igrated at similar speeds, treatment with anti-CTLA-4 led to
he increased motility of CTLA-4+/+ but not CTLA-4−/− cells.
urther experiments demonstrated that while anti-CD3 ligation
esulted in reduced movement of primary human and mouse T
ells, co-ligation of CTLA-4 reversed the arrest. The authors
rgued that this event could play a role in secondary immune
esponses where shorter dwell times are sufficient for activation.
TLA-4+ cells, with shorter dwell times due to the reversal of
he TCR stop signal, could therefore compete with CTLA-4−
ells which engage in longer conjugation with APCs. In addi-
ion, the shorter dwell time of CTLA-4+ may stop these cells
rom being activated by autoantigens, which would lead to the
utoimmune disease commonly observed in CTLA-4 deficient
ice.
In the current paper by Downey et al., the investigation into
he effect on T cell migration is taken one step further by looking
t CTLA-4 deficient mice with established lymphoproliferative
isease. Whereas CTLA-4 ligation on pre-activated T cells from
ealthy mice and humans in the previous study led to reversal of
he anti-CD3 induced TCR stop signal, CTLA-4−/− T cells from
iseased mice are now shown to have resistance to the induction
f a TCR stop signal by anti-CD3 ligation. It is therefore argued
hat in diseased animals, the TCR is decoupled from its normal
bility to induce a stop signal, resulting in the tissue infiltration
bserved in CTLA-4 deficient mice. Whether the decoupling
f the TCR stop signal is the result of the chronic illness in dis-
ased CTLA-4−/− mice or arises from a difference in the thymic
election of T cells in the absence of CTLA-4 remains unclear.comparison between the motility of T cells from CTLA-4−/−
nimals before and after the manifestation of disease may shed
ome light on this matter.
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The findings of the current study and the two previous stud-
es by the same group [8,9] may at first seem at odds with each
ther. It is clear, however, that these studies used different con-
itions and sources of cells, which could explain the disparity of
esults. Nevertheless, taken together they demonstrate the del-
cate balance required for T cell activation and regulation in
rder to achieve a healthy immune response. CTLA-4 seems to
lay a pivotal role in controlling each part of the three-way bal-
nce between the strength, quality and duration of signal which
etermines the outcome of an interaction between a T cell and
n APC. Exactly how CTLA-4 exerts its multidisciplinary effect
emains unclear, but may prove crucial in the understanding of
mmune regulation.
eferences
1] Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, et al.
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells
constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J
Exp Med 2000;192:303–10.
2] Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated
antigen 4 plays an essential role in the function of CD25+CD4+ regula-
tory cells that control intestinal inflammation. J Exp Med 2000;192:295–
302.
3] Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, Francisco L, et
al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their
function in vivo. J Immunol 2006;177:4376–83.
4] Eggena MP, Walker LS, Nagabhushanam V, Barron L, Chodos A, Abbas
AK. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an
islet cell antigen. J Exp Med 2004;199:1725–30.
5] Walker LS, Ausubel LJ, Chodos A, Bekarian N, Abbas AK. CTLA-4 dif-
ferentially regulates T cell responses to endogenous tissue protein versus
exogenous immunogen. J Immunol 2002;169:6202–9.Letters 115 (2008) 73–74
6] Buhlmann JE, Elkin SK, Sharpe AH. A role for the B7-1/B7-2:CD28/CTLA-
4 pathway during negative selection. J Immunol 2003;170:5421–8.
7] Kwon H, Jun HS, Khil LY, Yoon JW. Role of CTLA-4 in the acti-
vation of single- and double-positive thymocytes. J Immunol 2004;173:
6645–53.
8] Schneider H, Valk E, da Rocha Dias S, Wei B, Rudd CE. CTLA-4
up-regulation of lymphocyte function-associated antigen 1 adhesion and
clustering as an alternate basis for coreceptor function. Proc Natl Acad Sci
USA 2005;102:12861–6.
9] Schneider H, Downey J, Smith A, Zinselmeyer BH, Rush C, Brewer JM,
et al. Reversal of the TCR stop signal by CTLA-4. Science 2006;313:
1972–5.
Johan Verhagen ∗
Catherine A. Sabatos 1
David C. Wraith 1
Department of Cellular and Molecular Medicine, School of
Medical Sciences, University of Bristol, University Walk,
Bristol BS8 1TD, UK
∗ Corresponding author. Tel.: +44 117 3312008;
fax: +44 117 9287896.
E-mail addresses: Johan.Verhagen@bristol.ac.uk (J.
Verhagen), d.c.wraith@bristol.ac.uk (D.C. Wraith)
1 Tel.: +44 117 3312008; fax: +44 117 9287896.Available online 8 November 2007
